Actelion Ltd (SWX: ATLN) announced that Tracleer® (bosentan), a dual endothelin receptor antagonist, has been approved in the European Union for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH WHO functional class FC II). Buy acomplia pills Since 2002, Tracleer® Read the rest of this entry »